日本のゲノム編集の市場規模は、2024年に3億2,310万ドルと推定され、バイオテクノロジー研究への投資の増加、治療薬や農業への応用拡大、高度な遺伝子技術を促進する政府の支援イニシアチブに牽引され、2025年から2033年にかけてCAGR 17.97%で成長し、2033年には14億5,000万ドルに達すると予想されます。個別化医療、遺伝子治療、精密農業の需要が高まる中、日本企業や研究機関は、効率性と精度を高めるために、CRISPR-Casシステムなどの革新的なゲノム編集ツールを積極的に採用しています。例えば、2025年3月、日本の研究者は、CRISPR-Cas9を用いて遺伝子の機能を部分的に阻害するゲノム編集法を開発し、必須遺伝子を完全に不活性化することなく、精密な育種と作物のレジリエンスの向上を可能にしました。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Technology Segment
1.2.2. Method Segment
1.2.3. Application Segment
1.2.4. Mode Segment
1.2.5. End-use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Japan Genome Editing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Japan Genome Editing Market: Technology Business Analysis
4.1. Technology Segment Dashboard
4.2. Japan Genome Editing Market Technology Movement Analysis
4.3. Japan Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. CRISPR/Cas9
4.4.1. CRISPR/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
4.5. TALENs/MegaTALs
4.5.1. TALENS/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
4.6. ZFN
4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Meganucleases
4.7.1. Meganucleases market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Japan Genome Editing Market: Delivery Method Business Analysis
5.1. Delivery Method Segment Dashboard
5.2. Japan Genome Editing Market Delivery Method Movement Analysis
5.3. Japan Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
5.4. Ex-vivo
5.4.1. Ex-vivo market estimates and forecasts 2021 to 2033 (USD Million)
5.5. In- vivo
5.5.1. In-Vivo market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Japan Genome Editing Market: Application Business Analysis
6.1. Application Segment Dashboard
6.2. Japan Genome Editing Market Application Movement Analysis
6.3. Japan Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Genetic Engineering
6.4.1. Genetic Engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Cell line engineering
6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Animal genetic engineering
6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Plant genetic engineering
6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.5. Others
6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Clinical Applications
6.5.1. Clinical Applications market estimates and forecasts 2021 to 2033 (USD Million)
6.5.2. Therapy Development
6.5.2.1. Therapy Development market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. Diagnostics Development
6.5.3.1. Diagnostics Development market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Japan Genome Editing Market: Mode Business Analysis
7.1. Mode Segment Dashboard
7.2. Japan Genome Editing Market Mode Movement Analysis
7.3. Japan Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
7.4. Contract
7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
7.5. In- house
7.5.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Japan Genome Editing Market: End Use Estimates & Trend Analysis
8.1. End Use Segment Dashboard
8.2. Japan Genome Editing Market End Use Movement Analysis
8.3. Japan Genome Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Biotechnology & Pharmaceutical Companies
8.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Academic & Research Institutes
8.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Contract Research Organizations
8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Merck KGaA
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Takara Bio Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Revvity, Inc.
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Danaher Corporation
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. GenScript
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. New England Biolabs
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Lonza
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Thermo Fisher Scientific, Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Charles River Laboratories
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Eurofins Scientific
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Japan Genome editing Market, By technology, 2021 - 2033 (USD Million)
Table 5 Japan Genome editing Market, By delivery method, 2021 - 2033 (USD Million)
Table 6 Japan Genome editing Market, By application, 2021 - 2033 (USD Million)
Table 7 Japan Genome editing Market, By mode, 2021 - 2033 (USD Million)
Table 8 Japan Genome editing Market, By end use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Japan genome editing market segmentation
Fig. 2 Information procurement
Fig. 3 Data analysis models
Fig. 4 Market formulation and validation
Fig. 5 Data validating & publishing
Fig. 6 Market research process
Fig. 7 Information procurement
Fig. 8 Primary research
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Japan genome editing market: Technology outlook key takeaways
Fig. 13 Japan genome editing market: Technology movement analysis
Fig. 14 Japan CRISPR/Cas9 market, 2021 - 2033 (USD Million)
Fig. 15 Japan TALENs/MegaTALs market, 2021 - 2033 (USD Million)
Fig. 16 Japan ZFN market, 2021 - 2033 (USD Million)
Fig. 17 Japan meganucleases market, 2021 - 2033 (USD Million)
Fig. 18 Japan others market, 2021 - 2033 (USD Million)
Fig. 19 Japan genome editing market: Delivery Method outlook and key takeaways
Fig. 20 Japan genome editing market: Delivery Method movement analysis
Fig. 21 Japan ex- vivo market, 2021 - 2033 (USD Million)
Fig. 22 Japan in- vivo market, 2021 - 2033 (USD Million)
Fig. 23 Japan genome editing market: Application outlook and key takeaways
Fig. 24 Japan genome editing market: Application movement analysis
Fig. 25 Japan genetic engineering market, 2021 - 2033 (USD Million)
Fig. 26 Japan cell line engineering market, 2021 - 2033 (USD Million)
Fig. 27 Japan animal engineering market, 2021 - 2033 (USD Million)
Fig. 28 Japan plant engineering market, 2021 - 2033 (USD Million)
Fig. 29 Japan others market, 2021 - 2033 (USD Million)
Fig. 30 Japan clinical applications market, 2021 - 2033 (USD Million)
Fig. 31 Japan diagnostics development market, 2021 - 2033 (USD Million)
Fig. 32 Japan therapy development market, 2021 - 2033 (USD Million)
Fig. 33 Japan genome editing market: Mode outlook and key takeaways
Fig. 34 Japan genome editing market: Mode movement analysis
Fig. 35 Japan contract market, 2021 - 2033 (USD Million)
Fig. 36 Japan in- house market, 2021 - 2033 (USD Million)
Fig. 37 Japan genome editing market: End use outlook and key takeaways
Fig. 38 Japan genome editing market: End use movement analysis
Fig. 39 Japan biotechnology & pharmaceutical companies market, 2021 - 2033 (USD Million)
Fig. 40 Japan academic & research institutes market, 2021 - 2033 (USD Million)
Fig. 41 Japan contract research organizations market, 2021 - 2033 (USD Million)
